R Simó, A Lecube, J Genescà, JI Esteban, C … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Patients with normal fasting glucose (<100 mg/dl)
with biopsy-proven chronic hepatitis C without cirrhosis and with at least 3
years of follow-up after finishing antiviral therapy were included in the ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►vghtpe.gov.tw [PDF] HF Chen, CY Li, P Chen, TT See, HY Lee - Journal of the Chinese Medical Association, 2006 - Elsevier No significant difference was found between type 2 DM patients and the control
group for seropositivity of HBsAg (13.5% versus 12.4%; odds ratio [OR] = 1.09;
95% confidence interval [CI]: 0.77–1.55; p = 0.441), but anti-HCV ... Cited by 15 - Related articles - BL Direct - All 12 versions
T Kawaguchi, T Ide, E Taniguchi, E Hirano, … - American Journal of Gastroenterology, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 49 - Related articles - BL Direct - All 5 versions
C Giordanino, E Bugianesi, A Smedile, A … - Am J Gastroenterol, 2008 - canadiancpd.medscape.com If HCV is directly involved in the development of IR and DM, it is reasonable to
hypothesize that its clearance may result in a parallel decrease in the risk of
DM incidence. A recent study showed that in patients with genotype 1 ... Cited by 10 - Related articles - All 10 versions
- ►prbb.org [PDF] M Romero-Gómez, CM Fernández-Rodríguez, … - Journal of Hepatology, 2008 - Elsevier The SVR rate was lower in patients with IFG and/or T2DM than in patients with
normal glucose concentrations [143/325 (44%) vs. 432/734 (58.8%); P = 0.002]. In
the follow-up, abnormal glucose concentrations were observed in 74 of 304 ... Cited by 25 - Related articles - All 20 versions
F Imazeki, O Yokosuka, K Fukai, T Kanda, H … - Liver International, 2008 - phx1.medscape.com The liver is crucial to carbohydrate metabolism and glucose homoeostasis, and
hepatic dysfunction causes glucose abnormalities leading to DM, which is
prevalent in chronic liver disease, and especially in liver cirrhosis. ... Cited by 12 - Related articles - BL Direct - All 7 versions
JF Huang, CY Dai, SJ Hwang, CK Ho, PJ … - American Journal of Gastroenterology, 2007 - interscience.wiley.com OBJECTIVES: There is growing evidence with regard to the association between
hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM). However,
the mutual link and related virological implication have not been fully ... Cited by 15 - Related articles - BL Direct - All 5 versions
V Okan, M Araz, S Aktaran, T Karsligil, I … - International journal of clinical practice(Esher), 2002 - cat.inist.fr The aim of this study was to investigate the prevalence of hepatitis B and
hepatitis C virus infections in type 2 diabetic patients in Gaziantep, Turkey.
Six hundred and ninety-two type 2 diabetic patients and 1014 healthy blood ... Cited by 24 - Related articles - BL Direct - All 2 versions
A Lecube, C Hernández, J Genescà, R Simó - Diabetes Care, 2006 - Am Diabetes Assoc Hepatitis C virus (HCV) infection is a major cause of chronic liver disease,
affecting ∼3% of the world's population (1,2). The disease is characterized by
silent onset in most infected individuals (3), and recent studies indicate ... Cited by 29 - Related articles - BL Direct - All 8 versions
S Rudoni, JM Petit, JB Bour, LS Aho, A … - Diabetes & metabolism, 1999 - ncbi.nlm.nih.gov An increased prevalence of hepatitis C virus (HCV) infection in patients with
diabetes mellitus has suggested a link between these two conditions and the
possibility of patient-to-patient HCV transmission during hospital ... Cited by 21 - Related articles - All 2 versions
